Finally, of the neoadjuvant gem-RT group, there was a higher ratio of CD163+ macrophages compared to CD8 cells in the tumor tissue, suggesting a more immune suppressive profile in the tumor tissue (Fig. 3G). The gene discussed is CD163; the disease is neoplasm.